Defining Nonresponse to PBC Treatment: Curbside Consults Podcast
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
Defining Nonresponse to PBC Treatment: Curbside Consults Podcast
-
Narrado por:
-
De:
Acerca de esta escucha
How do you decide when to move from first-line to second-line treatment for primary biliary cholangitis (PBC)? In this podcast, listen as experts Alan Bonder, MD, AGAF, and Aparna Goel, MD, discuss this question and more, including:
- How and when to measure treatment response
- Evidence-based goals of therapy
- Considerations for second-line treatment
- New agents for second-line treatment: PPAR agonists
Presenters:
Alan Bonder, MD, AGAF
Associate Professor of Medicine
Medical Director of Liver Transplant
Department of Gastroenterology
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts
Aparna Goel, MD
Associate Clinical Professor of Medicine
Division of Gastroenterology and Hepatology
Stanford University
Palo Alto, California
Content based on an online CME program supported by independent educational grants from Gilead Sciences, Inc., and Ipsen Biopharmaceuticals, Inc.
To learn more about PBC management, check out our program,
Curbside Consults: Expert Insights on Challenges in PBC Management.
Supported by educational grants from Gilead Sciences, Inc. and Ipsen Biopharmaceuticals, Inc